Pharmaceutical Value proposition
[Automatic translation follows] Chugai Pharmaceutical (headquarters: Tokyo) is a research and development-based pharmaceutical company with strengths in its unique drug discovery technology platform, including antibody engineering technology. As an important member of the Roche Group and a listed company on the Tokyo Stock Exchange Prime Market, Chugai is committed to creating innovative medicines that meet unmet medical needs under an independent management system. Please refer to our Social Media Policy for use:
https://www.chugai-pharm.co.jp/rule/sns/index.html
Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai is committed to creating innovative pharmaceutical products that may satisfy unmet medical needs. Chugai is listed on the Prime Market of the Tokyo Stock Exchange. While maintaining autonomy and managing independence, Chugai is an important member of the Roche Group. Additional information is available at https://www.chugai-pharm.co.jp/english/
Read our Social Media Policy: https://www.chugai-pharm.co.jp/english/rule/sns/index.html
Pharmaceuticals, New Drug Development, Global Companies, and BiopharmaceuticalsOriginal language
中外製薬(本社:東京)は、抗体エンジニアリング技術をはじめとする独自の創薬技術基盤を強みとする、研究開発型の製薬企業です。ロシュ・グループの重要なメンバーであるとともに、東京証券取引所プライム市場の上場企業として、自主独立経営の下、アンメットメディカルニーズを満たす革新的な医薬品の創製に取り組んでいます。
ご利用にあたってはソーシャルメディアポリシーをご覧ください:
https://www.chugai-pharm.co.jp/rule/sns/index.html
Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai is committed to creating innovative pharmaceutical products that may satisfy unmet medical needs. Chugai is listed on the Prime Market of the Tokyo Stock Exchange. While maintaining autonomy and management independence, Chugai is an important member of the Roche Group. Additional information is available at https://www.chugai-pharm.co.jp/english/
Read our Social Media Policy: https://www.chugai-pharm.co.jp/english/rule/sns/index.html
製薬, 新薬開発, グローバル企業, and バイオ医薬品
中外製薬株式会社｜創造で、想像を超える。
中外製薬株式会社｜創造で、想像を超える。
https://www.chugai-pharm.co.jp/
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Deep Knowledge Analytics it services, Research Services | Other 31 Aug 2024 | | |
 | Klineo deeptech, healthtech | Other 16 Oct 2024 | | |
 | Access Accelerated cleantech, Civic and Social Organizations | Other 15 Jun 2024 | | |
 | Cumulus Neuroscience biotech, deeptech, healthtech, Biotechnology Research | Other 6 Jun 2024 | | |
 | Flying Health fintech, entrepreneurship, deeptech, healthtech, Business Consulting and Services | Other 15 May 2023 | | |